Healthcare Sales & Marketing Network News: severe primary IGFD

Searching News Database: severe primary IGFD

HSMN NewsFeed - 16 Jun 2008
Tercica Announces Results from Increlex(R) IGFD Patient Registry and Other Increlex(R) Studies at the 90th Meeting of the Endocrine Society
Biopharmaceuticals

HSMN NewsFeed - 9 Aug 2007
IPSEN: Increlex(R) Receives Marketing Authorisation in the European Union
Biopharmaceuticals Regulatory

HSMN NewsFeed - 8 Aug 2007
Tercica Receives Marketing Approval for Increlex in the European Union
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 25 May 2007
Ipsen: Increlex(R) Receives CHMP Positive Opinion for the Treatment of Severe Primary IGF-1 Deficiency
Biopharmaceuticals Regulatory

HSMN NewsFeed - 16 Oct 2006
Insmed Sues Tercica for False Advertising
Biopharmaceuticals Litigation

HSMN NewsFeed - 5 Jul 2006
Court Rules Insmed Infringes Tercica IGF-1 Process Patent
Biopharmaceuticals Litigation

Return to NewsFeed

Additional items found! 10

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 10 additional stories matching:
severe primary IGFD
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.